ABC of monitoring drug therapy. Digoxin.

ABC of monitoring drug therapy. Digoxin.

Bibliográfalaš dieđut
Váldodahkkit:	Aronson, J, Hardman, M
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1992

Geahča maid

ABC of monitoring drug therapy. Why monitor drug therapy?
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

ABC of monitoring drug therapy. Patient compliance.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

ABC of monitoring drug therapy. Theophylline.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

ABC of monitoring drug therapy. Phenytoin.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

ABC of monitoring drug therapy. Measuring plasma drug concentrations.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1978)

Monitoring digoxin therapy: III. How useful are the nomograms?
Dahkki: Aronson, J
Almmustuhtton: (1978)

ABC of monitoring drug therapy. Lithium.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

ABC of monitoring drug therapy. Cyclosporin.
Dahkki: Reynolds, D, et al.
Almmustuhtton: (1992)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1977)

ABC of monitoring drug therapy. Aminoglycoside antibiotics.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1992)

Digoxin revisited.
Dahkki: Aronson, J
Almmustuhtton: (1998)

Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
Dahkki: Rony Abdi Syahputra, et al.
Almmustuhtton: (2022-04-01)

ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.
Dahkki: Reynolds, D, et al.
Almmustuhtton: (1993)

Interaction of digoxin with quinine.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1981)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
Dahkki: S. F. Zadvorev, et al.
Almmustuhtton: (2018-05-01)

Clinical pharmacokinetics of digoxin 1980.
Dahkki: Aronson, J
Almmustuhtton: (1980)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1977)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
Dahkki: Ford, A, et al.
Almmustuhtton: (1979)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
Dahkki: Aronson, J, et al.
Almmustuhtton: (1983)

Indications for the measurement of plasma digoxin concentrations.
Dahkki: Aronson, J
Almmustuhtton: (1983)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
Dahkki: M Yurdakök, et al.
Almmustuhtton: (1989-10-01)

Appropriateness of digoxin level monitoring
Dahkki: MR Mordasini, et al.
Almmustuhtton: (2002-09-01)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
Dahkki: Aronson, J, et al.
Almmustuhtton: (1980)

In vivo cation transport during short-term and long-term digoxin therapy.
Dahkki: Boon, N, et al.
Almmustuhtton: (1986)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
Dahkki: Boon, N, et al.
Almmustuhtton: (1984)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
Dahkki: Ford, A, et al.
Almmustuhtton: (1979)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
Dahkki: Pugh, S, et al.
Almmustuhtton: (1982)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
Dahkki: Aronson, J, et al.
Almmustuhtton: (1982)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
Dahkki: Sophia Sheikh, et al.
Almmustuhtton: (2024-06-01)

Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods
Dahkki: Isabel Cristina Medeiros Barros, et al.
Almmustuhtton: (2014-01-01)

Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care
Dahkki: Emma M García-Iranzo, et al.
Almmustuhtton: (2017-07-01)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
Dahkki: Zeynep ÖZTÜRK, et al.
Almmustuhtton: (2018-01-01)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
Dahkki: Antonella Colella, et al.
Almmustuhtton: (2022-06-01)

Monitoring drug therapy.
Dahkki: Buclin, T, et al.
Almmustuhtton: (2012)

Neglected facts in digoxin intoxication
Dahkki: Sibel Ocak Serin
Almmustuhtton: (2017-06-01)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
Dahkki: Marcin Wais, et al.
Almmustuhtton: (2024-04-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
Dahkki: Tadej Petreski, et al.
Almmustuhtton: (2023-08-01)

The effects of digoxin and dopamine on the oxygen consumption, lactate production and performance of an isolated, perfused working guinea-pig heart
Dahkki: Zannad, F, et al.
Almmustuhtton: (1982)

THE EFFECTS OF DIGOXIN AND DOPAMINE ON THE OXYGEN-CONSUMPTION, LACTATE PRODUCTION AND PERFORMANCE OF AN ISOLATED, PERFUSED WORKING GUINEA-PIG HEART
Dahkki: Zannad, F, et al.
Almmustuhtton: (1982)